Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

MK-462;Maxalt;Maxalt

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

34 API Suppliers, 21 USDMF, 12 CEP/COS, 4 JDMF, 16 EU WC, 13 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

305 FDF Dossiers, 55 FDA Orange Book, 160 Europe, 39 Canada, 6 Australia, 17 South Africa, 28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 6 Rochem International Inc, 19 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 6 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 ACG Worldwide, 3 Actylis, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 6 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 6 DFE Pharma, 9 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 31 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 45 Disintegrants & Superdisintegrants, 32 Direct Compression, 28 Taste Masking, 23 Granulation, 22 Chewable & Orodispersible Aids, 22 Thickeners and Stabilizers, 22 Controlled & Modified Release, 19 Co-Processed Excipients, 16 Lubricants & Glidants, 16 Film Formers & Plasticizers, 9 Parenteral, 9 Empty Capsules, 5 Solubilizers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 3 Topical, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Stock Recap #PipelineProspector, 17 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 160 Regulatory FDF Prices

MARKET PLACE

9 APIs

9 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM

2 EDQM

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
04/06/2025	Inke S.A	Spain	INKE SA	25623	RIZATRIPTAN BENZOATE	2011-12-22	Active	II	N/A
04/06/2025	Unimark Remedies	India	UNIMARK REMEDIES LTD	24177	RIZATRIPTAN BENZOATE	2010-09-27	Active	II	Complete	2014-07-01	2014-03-24

MK-462;Maxalt;Maxalt

MK-462;Maxalt;Maxalt

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

34 API Suppliers

21 USDMF

12 CEP/COS

4 JDMF

16 EU WC

13 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

305 FDF Dossiers

55 FDA Orange Book

160 Europe

39 Canada

6 Australia

17 South Africa

28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Evonik

6 Rochem International Inc

19 SPI Pharma

7 DKSH

1 Pharm-RX Chemical

6 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

10 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

4 ACG Worldwide

3 Actylis

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

6 BASF

1 Bioplus Life Sciences

11 Corel Pharma Chem

6 DFE Pharma

9 Gangwal Chemicals

4 Ideal Cures

5 Ingredion Pharma Solutions

31 Kerry

4 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

5 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

29 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

4 Silverline Chemicals

1 Symrise

3 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem

2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons